Author: Scott Hickman
Blog Scott Hickman
DDSC In Vivo ADME Expertise Providing Cost Savings
- Updated Offerings
- November 19, 2019
- Scott Hickman
ADME studies are a vital part of the drug development process, and therefore, deciding where and how to perform these studies...
To GLP or not to GLP?
- Regulatory Guidance
- October 5, 2018
- Scott Hickman, Dr. Brian Ogilvie, Tim Patterson
That is the question. . . Knowing the answer may save you time and money Good Laboratory Practices (GLP) are...
Cypex Expands Portfolio of Recombinant Enzymes
- Non-CYP Enzymes
- September 18, 2018
- Scott Hickman
As a distributor for Cypex in the US and Canada, XenoTech is proud to offer this portfolio of products based on patented...
IQ Induction Working Group Publishes Recommendations for Data Interpretation of In Vitro Induction – Focus on CYP3A4 mRNA
- Enzyme Induction
- July 13, 2018
- Scott Hickman, Dr. Brian Ogilvie
XenoTech is proud to have made contributions to the paper entitled, “Considerations from the IQ Induction Working Group in Response...
New Guidance on Bioanalytical Services
- Regulatory Guidance
- July 6, 2018
- Scott Hickman, Seema Muranjan
XenoTech offers bioanalytical services to support both internal groups and external clients. We have validated LC-MS/MS methods for human CYP markers, UDP...
Subscribe to our Newsletter
Stay up to date with our news, events and research
Do you have a question or a request for upcoming blog content?
We love to get your feedback